43 related articles for article (PubMed ID: 28242377)
1. P-Glycoprotein in skin contributes to transdermal absorption of topical corticosteroids.
Hashimoto N; Nakamichi N; Yamazaki E; Oikawa M; Masuo Y; Schinkel AH; Kato Y
Int J Pharm; 2017 Apr; 521(1-2):365-373. PubMed ID: 28242377
[TBL] [Abstract][Full Text] [Related]
2. ATP binding cassette transporters in two distinct compartments of the skin contribute to transdermal absorption of a typical substrate.
Hashimoto N; Nakamichi N; Uwafuji S; Yoshida K; Sugiura T; Tsuji A; Kato Y
J Control Release; 2013 Jan; 165(1):54-61. PubMed ID: 23089896
[TBL] [Abstract][Full Text] [Related]
3. Impact of genetic deficiencies of P-glycoprotein and breast cancer resistance protein on pharmacokinetics of aripiprazole and dehydroaripiprazole.
Nagasaka Y; Sano T; Oda K; Kawamura A; Usui T
Xenobiotica; 2014 Oct; 44(10):926-32. PubMed ID: 24666334
[TBL] [Abstract][Full Text] [Related]
4. Impact of P-glycoprotein and breast cancer resistance protein on the brain distribution of antiepileptic drugs in knockout mouse models.
Nakanishi H; Yonezawa A; Matsubara K; Yano I
Eur J Pharmacol; 2013 Jun; 710(1-3):20-8. PubMed ID: 23588114
[TBL] [Abstract][Full Text] [Related]
5. Metabolome Analysis Reveals Dermal Histamine Accumulation in Murine Dermatitis Provoked by Genetic Deletion of P-Glycoprotein and Breast Cancer Resistance Protein.
Hashimoto N; Nakamichi N; Nanmo H; Kimura KI; Masuo Y; Sakai Y; Schinkel AH; Sato S; Soga T; Kato Y
Pharm Res; 2019 Sep; 36(11):158. PubMed ID: 31512001
[TBL] [Abstract][Full Text] [Related]
6. Brain penetration of WEB 2086 (Apafant) and dantrolene in Mdr1a (P-glycoprotein) and Bcrp knockout rats.
Fuchs H; Kishimoto W; Gansser D; Tanswell P; Ishiguro N
Drug Metab Dispos; 2014 Oct; 42(10):1761-5. PubMed ID: 25053619
[TBL] [Abstract][Full Text] [Related]
7. Use of cassette dosing approach to examine the effects of P-glycoprotein on the brain and cerebrospinal fluid concentrations in wild-type and P-glycoprotein knockout rats.
Liu X; Cheong J; Ding X; Deshmukh G
Drug Metab Dispos; 2014 Apr; 42(4):482-91. PubMed ID: 24398459
[TBL] [Abstract][Full Text] [Related]
8. P-glycoprotein (Abcb1) is involved in absorptive drug transport in skin.
Ito K; Nguyen HT; Kato Y; Wakayama T; Kubo Y; Iseki S; Tsuji A
J Control Release; 2008 Nov; 131(3):198-204. PubMed ID: 18725258
[TBL] [Abstract][Full Text] [Related]
9. Influx and Efflux Transporters Contribute to the Increased Dermal Exposure to Active Metabolite of Regorafenib After Repeated Oral Administration in Mice.
Al-Shammari AH; Masuo Y; Fujita KI; Yoshikawa Y; Nakamichi N; Kubota Y; Sasaki Y; Kato Y
J Pharm Sci; 2019 Jun; 108(6):2173-2179. PubMed ID: 30685396
[TBL] [Abstract][Full Text] [Related]
10. Quantitative Targeted Absolute Proteomics of Transporters and Pharmacoproteomics-Based Reconstruction of P-Glycoprotein Function in Mouse Small Intestine.
Akazawa T; Uchida Y; Tachikawa M; Ohtsuki S; Terasaki T
Mol Pharm; 2016 Jul; 13(7):2443-56. PubMed ID: 27276518
[TBL] [Abstract][Full Text] [Related]
11. P-glycoprotein plays a major role in the efflux of fexofenadine in the small intestine and blood-brain barrier, but only a limited role in its biliary excretion.
Tahara H; Kusuhara H; Fuse E; Sugiyama Y
Drug Metab Dispos; 2005 Jul; 33(7):963-8. PubMed ID: 15821041
[TBL] [Abstract][Full Text] [Related]
12. Characterization of P-Glycoprotein Inhibitors for Evaluating the Effect of P-Glycoprotein on the Intestinal Absorption of Drugs.
Kono Y; Kawahara I; Shinozaki K; Nomura I; Marutani H; Yamamoto A; Fujita T
Pharmaceutics; 2021 Mar; 13(3):. PubMed ID: 33804018
[TBL] [Abstract][Full Text] [Related]
13. The Differential Absorption of a Series of P-Glycoprotein Substrates in Isolated Perfused Lungs from Mdr1a/1b Genetic Knockout Mice can be Attributed to Distinct Physico-Chemical Properties: an Insight into Predicting Transporter-Mediated, Pulmonary Specific Disposition.
Price DF; Luscombe CN; Eddershaw PJ; Edwards CD; Gumbleton M
Pharm Res; 2017 Dec; 34(12):2498-2516. PubMed ID: 28702798
[TBL] [Abstract][Full Text] [Related]
14. Verification of P-Glycoprotein Function at the Dermal Barrier in Diffusion Cells and Dynamic "Skin-On-A-Chip" Microfluidic Device.
Bajza Á; Kocsis D; Berezvai O; Laki AJ; Lukács B; Imre T; Iván K; Szabó P; Erdő F
Pharmaceutics; 2020 Aug; 12(9):. PubMed ID: 32854319
[TBL] [Abstract][Full Text] [Related]
15. Chromatographic determination of percutaneous absorption of topical non-radiolabelled prednisolone in vivo, and preliminary application to transdermal pharmacokinetics.
Kubota K; Ishizaki T; Oka K
J Chromatogr; 1989 Sep; 493(2):373-9. PubMed ID: 2584303
[No Abstract] [Full Text] [Related]
16. Clarifications: Dermal Clearance Model for Epidermal Bioavailability Calculations.
Kapoor Y; Milewski M; Mitra A; Kasting GB
J Pharm Sci; 2016 Mar; 105(3):1341-4. PubMed ID: 26886328
[TBL] [Abstract][Full Text] [Related]
17. Percutaneous absorption of dexamethasone acetate and palmitate, and the plasma concentration.
Ogiso T; Ito Y; Iwaki M; Atago H; Tanaka C; Maniwa N; Ishida S
Chem Pharm Bull (Tokyo); 1987 Oct; 35(10):4263-70. PubMed ID: 3435951
[No Abstract] [Full Text] [Related]
18. An innovative small molecule for promoting neuroreparative strategies.
Colabufo NA; Contino M; Cantore M; Berardi F; Perrone R; Tonazzi A; Console L; Panaro MA; Savolainen H; Luurtsema G
RSC Adv; 2018 Jan; 8(10):5451-5458. PubMed ID: 35542423
[TBL] [Abstract][Full Text] [Related]
19. Absorption of Drugs through the Skin.
Hospital (Lond 1886); 1908 Mar; 43(1126):679-680. PubMed ID: 29842017
[No Abstract] [Full Text] [Related]
20. Involvement of the Transporters P-Glycoprotein and Breast Cancer Resistance Protein in Dermal Distribution of the Multikinase Inhibitor Regorafenib and Its Active Metabolites.
Fujita KI; Masuo Y; Yamazaki E; Shibutani T; Kubota Y; Nakamichi N; Sasaki Y; Kato Y
J Pharm Sci; 2017 Sep; 106(9):2632-2641. PubMed ID: 28479358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
